PURE Bioscience, Inc.

OTC:PURE

0.107 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 1.9631.8771.8533.9276.9171.9091.7741.8311.2890.7290.550.820.8120.4641.4360.7281.4870.3360.20.1560.2632.5893.2062.411.6613.41.710.8
Cost of Revenue 0.8110.9060.8531.8522.8960.7280.7630.760.4410.2850.3440.5650.2640.1310.4650.2380.4640.2210.1060.0520.1311.5341.5991.3630.8851.30.90.60.6
Gross Profit 1.1520.97112.0754.0211.1811.0111.0710.8480.4440.2060.2550.5480.3330.9710.491.0240.1150.0950.1040.1331.0561.6081.0470.7762.10.80.40.2
Gross Profit Ratio 0.5870.5170.540.5280.5810.6190.570.5850.6580.6090.3750.3110.6750.7170.6760.6730.6880.3430.4730.6690.5030.4080.5010.4350.4670.6180.4710.40.25
Reseach & Development Expenses 0.3020.2970.3190.3390.3220.3540.4590.7790.9270.791.0321.3251.8632.181.9271.4681.6461.2211.1941.3571.1330.9810.7810.2930.1150.20.200
General & Administrative Expenses 0004.04706.4167.5946.36.9787.2948.3225.7187.4396.524.9345.4625.1433.7352.6131.758000000000
Selling & Marketing Expenses 000000000000000.9280.6940.8060.8990.570.427000000000
SG&A 3.9814.3024.1064.0473.6956.4167.5946.36.9787.2948.3225.7187.4396.525.8626.1565.9493.7352.6131.7581.6263.2842.772.5722.3081.52.41.90.7
Other Expenses 0-0.0040-0.0040.0050.0010.0250000000000.109000000.27800.2120.10.10.10
Operating Expenses 4.2834.5994.4254.3864.0176.778.0537.0797.9058.0849.3547.0439.3028.77.7897.6257.7044.9563.8073.1152.7594.2653.8282.8652.6351.82.720.7
Operating Income -3.191-3.943-3.425-2.3110.009-5.589-7.042-6.0080.247-7.64-9.148-6.788-8.754-8.367-6.818-7.134-6.68-4.841-3.713-3.011-2.626-3.21-2.22-1.818-1.8590.3-1.9-1.6-0.5
Operating Income Ratio -1.626-2.101-1.848-0.5880.001-2.928-3.97-3.2810.192-10.48-16.633-8.278-10.781-18.025-4.748-9.797-4.491-14.39-18.523-19.326-9.968-1.239-0.692-0.755-1.1190.088-1.118-1.6-0.625
Total Other Income Expenses Net -0.159-0.319-0.066-0.008-0.005-0.965-0.4-0.255-14.6180.013-1.902-0.8830.0080.010.060.070.1420.1880.032-0.001-0.0730.023-0.280.0380.035000.20
Income Before Tax -3.35-3.961-3.491-2.3190.004-6.554-7.442-6.263-14.371-7.627-11.05-7.671-8.746-8.357-6.758-7.065-6.538-4.652-3.681-3.012-2.7-3.187-2.5-1.781-1.82500-1.40
Income Before Tax Ratio -1.707-2.11-1.884-0.5910.001-3.433-4.195-3.421-11.149-10.462-20.091-9.355-10.771-18.004-4.706-9.701-4.395-13.831-18.363-19.331-10.246-1.231-0.78-0.739-1.09800-1.40
Income Tax Expense -0.1480.010.006-0.0690.010.0070.0330.2557.314-0.0131.9020.8830.136-0.0180.0030.0020.0020.0020.132-1.165-0.3190.0740.2250.0020.00100-0.2-0.1
Net Income -3.35-3.961-3.497-2.319-0.006-6.561-7.475-6.518-21.685-7.614-12.952-8.554-8.882-8.339-6.76-7.067-6.54-4.655-3.813-1.847-2.381-3.261-2.725-1.782-1.8250.3-1.9-1.2-0.4
Net Income Ratio -1.707-2.11-1.887-0.591-0.001-3.437-4.214-3.56-16.823-10.444-23.549-10.432-10.938-17.965-4.707-9.704-4.397-13.838-19.023-11.855-9.036-1.259-0.85-0.74-1.0990.088-1.118-1.2-0.5
EPS -0.03-0.036-0.039-0.027-0-0.09-0.11-0.1-0.38-0.19-0.51-0.79-1.58-1.79-1.57-1.85-1.9-1.52-1.49-0.92-1.55-2.86-2.85-2.24-3.010.47-3.92-2.88-1.12
EPS Diluted -0.03-0.036-0.039-0.027-0-0.09-0.11-0.1-0.38-0.19-0.51-0.79-1.58-1.79-1.57-1.85-1.9-1.52-1.49-0.92-1.55-2.86-2.85-2.24-1.810.31-3.92-2.88-1.12
EBITDA -3.047-3.515-3.212-2.1430.201-5.347-6.732-5.4820.466-7.455-7.008-6.187-8.377-7.906-6.376-6.738-6.277-4.621-3.402-2.706-2.278-2.896-1.485-1.528-1.6070.4-1.8-1.7-0.5
EBITDA Ratio -1.552-1.873-1.733-0.5460.029-2.801-3.795-2.9940.362-10.226-12.742-7.545-10.317-17.033-4.44-9.252-4.22-13.738-16.972-17.365-8.644-1.118-0.463-0.634-0.9670.118-1.059-1.7-0.625